Zobrazeno 1 - 10
of 49
pro vyhledávání: '"ENITEC"'
Autor:
Casper Reijnen, Evangelia Gogou, Nicole C M Visser, Hilde Engerud, Jordache Ramjith, Louis J M van der Putten, Koen van de Vijver, Maria Santacana, Peter Bronsert, Johan Bulten, Marc Hirschfeld, Eva Colas, Antonio Gil-Moreno, Armando Reques, Gemma Mancebo, Camilla Krakstad, Jone Trovik, Ingfrid S Haldorsen, Jutta Huvila, Martin Koskas, Vit Weinberger, Marketa Bednarikova, Jitka Hausnerova, Anneke A M van der Wurff, Xavier Matias-Guiu, Frederic Amant, ENITEC Consortium, Leon F A G Massuger, Marc P L M Snijders, Heidi V N Küsters-Vandevelde, Peter J F Lucas, Johanna M A Pijnenborg
Publikováno v:
PLoS Medicine, Vol 17, Iss 5, p e1003111 (2020)
BACKGROUND:Bayesian networks (BNs) are machine-learning-based computational models that visualize causal relationships and provide insight into the processes underlying disease progression, closely resembling clinical decision-making. Preoperative id
Externí odkaz:
https://doaj.org/article/2c91f1408d514e2686d60f6f1e077189
Autor:
Willem Jan van Weelden, Leon F. A. G. Massuger, ENITEC, Johanna M. A. Pijnenborg, Andrea Romano
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Introduction: Hormonal therapy in endometrial cancer (EC) is used for patients who wish to preserve fertility and for patients with advanced or recurrent disease in a palliative setting. First line hormonal therapy consists of treatment with progesti
Externí odkaz:
https://doaj.org/article/398f89a73e4542928755bc67e32bf4db
Autor:
Gonda FJ Konings, Niina Saarinen, Bert Delvoux, Loes Kooreman, Pasi Koskimies, Camilla Krakstad, Kristine E. Fasmer, Ingfrid S. Haldorsen, Amina Zaffagnini, Merja R. Häkkinen, Seppo Auriola, Ludwig Dubois, Natasja Lieuwes, Frank Verhaegen, Lotte EJR Schyns, Roy FPM Kruitwagen, ENITEC Consortium, Sofia Xanthoulea, Andrea Romano
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 9, p 2547 (2018)
Endometrial cancer (EC) is the most common gynaecological malignancy in Western society and the majority of cases are estrogen dependent. While endocrine drugs proved to be of insufficient therapeutic value in the past, recent clinical research shows
Externí odkaz:
https://doaj.org/article/b36a8af33c9843f7928573c3e44a0db3
Autor:
Pijnenborg, Marike S. Lombaers, Karlijn M. C. Cornel, Nicole C. M. Visser, Johan Bulten, Heidi V. N. Küsters-Vandevelde, Frédéric Amant, Dorry Boll, Peter Bronsert, Eva Colas, Peggy M. A. J. Geomini, Antonio Gil-Moreno, Dennis van Hamont, Jutta Huvila, Camilla Krakstad, Arjan A. Kraayenbrink, Martin Koskas, Gemma Mancebo, Xavier Matías-Guiu, Huy Ngo, Brenda M. Pijlman, Maria Caroline Vos, Vit Weinberger, Marc P. L. M. Snijders, Sebastiaan W. van Koeverden, ENITEC-Consortium ENITEC-Consortium, Ingfrid S. Haldorsen, Casper Reijnen, Johanna M. A.
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2605
Patients with high-grade endometrial carcinoma (EC) have an increased risk of tumor spread and lymph node metastasis (LNM). Preoperative imaging and CA125 can be used in work-up. As data on cancer antigen 125 (CA125) in high-grade EC are limited, we
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Niina Saarinen, Gonda Konings, Roy F.P.M. Kruitwagen, Enitec, Elisabetta d'Avanzo, Loes F. S. Kooreman, Seppo Auriola, Florian Caiment, Frank Verhaegen, Sofia Xanthoulea, Youssef Walid, B. Delvoux, Natasja G. Lieuwes, Pasi Koskimies, Merja R. Häkkinen, Andrea Romano
Publikováno v:
Cancer Letters, 508, 18-29. Elsevier Ireland Ltd
Endometrial cancer (EC) is the most common gynaecological tumor in developed countries and its incidence is increasing. Approximately 80% of newly diagnosed EC cases are estrogen-dependent. Type 1 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD-1)
Autor:
Markus Jaeger, D Weiß, ENITEC-consortium, Hannah Donkers, Marc Hirschfeld, Ruud L.M. Bekkers, Thalia Erbes, Johanna M.A. Pijnenborg, Khadra Galaal
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica, 100(6), 1148-1154. Wiley
Acta Obstetricia et Gynecologica Scandinavica, 100, 6, pp. 1148-1154
Acta Obstetricia et Gynecologica Scandinavica, 100, 1148-1154
Acta Obstetricia et Gynecologica Scandinavica, 100, 6, pp. 1148-1154
Acta Obstetricia et Gynecologica Scandinavica, 100, 1148-1154
Item does not contain fulltext INTRODUCTION: MicroRNAs (miRNAs) are noncoding RNAs that regulate gene expression and contribute to the development of cancer. They have been shown to be stable in tissue samples and may be promising diagnostic biomarke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d1beed89465520b1271f47535fbf65
https://cris.maastrichtuniversity.nl/en/publications/653e144d-dc5c-4388-9939-a9eb5e37601d
https://cris.maastrichtuniversity.nl/en/publications/653e144d-dc5c-4388-9939-a9eb5e37601d
Publikováno v:
Frontiers in Oncology, 9
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Contains fulltext : 205365.pdf (Publisher’s version ) (Open Access) Introduction: Hormonal therapy in endometrial cancer (EC) is used for patients who wish to preserve fertility and for patients with advanced or recurrent disease in a palliative se
Autor:
Vrede, S. W., Van Weelden, Willem Jan, Visser, N. C. M., Bulten, Johan, van der Putten, Louis J. M., van de Vijver, Koen, Santacana Espasa, Maria, Colàs Campàs, Laura, Gil-Moreno, Antonio, Moiola, Cristian P., Mancebo, Gemma, Krakstad, Camilla, Trovik, Jone, Haldorsen, Ingfrid S., Huvila, Jutta, Koskas, Martin, Weinberger, Vit, Bednarikova, M., Hausnerova, Jitka, van der Wurff, Anneke A. M., Matias-Guiu, Xavier, Amant, Frederic, ENITEC Consortium, Snijders, Marc P. L. M., Küsters-Vandevelde, Heidi V. N, Reijnen, Casper, Pijnenborg, Johanna M. A.
Publikováno v:
Gynecologic Oncology, 161, 787-794
Gynecologic Oncology
Repositorio Abierto de la UdL
Universitad de Lleida
Scientia
GYNECOLOGIC ONCOLOGY
Gynecologic Oncology, 161, 3, pp. 787-794
Gynecologic oncology, 161(3), 787-794. Academic Press Inc.
Gynecologic Oncology
Repositorio Abierto de la UdL
Universitad de Lleida
Scientia
GYNECOLOGIC ONCOLOGY
Gynecologic Oncology, 161, 3, pp. 787-794
Gynecologic oncology, 161(3), 787-794. Academic Press Inc.
Objective. Pre-operative immunohistochemical (IHC) biomarkers are not incorporated in endometrial cancer (EC) risk classification. We aim to investigate the added prognostic relevance of IHC biomarkers to the ESMOESGO-ESTRO risk classification and ly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0b055763b5e3d4f46151cd0216a6819
http://hdl.handle.net/2066/234186
http://hdl.handle.net/2066/234186
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.